These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38619853)

  • 1. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
    Kouri N; Frankenhauser I; Peng Z; Labuzan SA; Boon BDC; Moloney CM; Pottier C; Wickland DP; Caetano-Anolles K; Corriveau-Lecavalier N; Tranovich JF; Wood AC; Hinkle KM; Lincoln SJ; Spychalla AJ; Senjem ML; Przybelski SA; Engelberg-Cook E; Schwarz CG; Kwan RS; Lesser ER; Crook JE; Carter RE; Ross OA; Lachner C; Ertekin-Taner N; Ferman TJ; Fields JA; Machulda MM; Ramanan VK; Nguyen AT; Reichard RR; Jones DT; Graff-Radford J; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K; Day GS; Duara R; Graff-Radford NR; Dickson DW; Lowe VJ; Vemuri P; Murray ME
    JAMA Neurol; 2024 Jun; 81(6):619-629. PubMed ID: 38619853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
    Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
    JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.
    Fleisher AS; Pontecorvo MJ; Devous MD; Lu M; Arora AK; Truocchio SP; Aldea P; Flitter M; Locascio T; Devine M; Siderowf A; Beach TG; Montine TJ; Serrano GE; Curtis C; Perrin A; Salloway S; Daniel M; Wellman C; Joshi AD; Irwin DJ; Lowe VJ; Seeley WW; Ikonomovic MD; Masdeu JC; Kennedy I; Harris T; Navitsky M; Southekal S; Mintun MA;
    JAMA Neurol; 2020 Jul; 77(7):829-839. PubMed ID: 32338734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
    Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
    Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
    Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME
    Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging.
    Charil A; Shcherbinin S; Southekal S; Devous MD; Mintun M; Murray ME; Miller BB; Schwarz AJ
    J Alzheimers Dis; 2019; 71(3):1037-1048. PubMed ID: 31476153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
    Ossenkoppele R; Lyoo CH; Jester-Broms J; Sudre CH; Cho H; Ryu YH; Choi JY; Smith R; Strandberg O; Palmqvist S; Kramer J; Boxer AL; Gorno-Tempini ML; Miller BL; La Joie R; Rabinovici GD; Hansson O
    JAMA Neurol; 2020 May; 77(5):632-642. PubMed ID: 32091549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
    Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
    Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
    Ghirelli A; Tosakulwong N; Weigand SD; Clark HM; Ali F; Botha H; Duffy JR; Utianski RL; Buciuc M; Murray ME; Labuzan SA; Spychalla AJ; Pham NTT; Schwarz CG; Senjem ML; Machulda MM; Baker M; Rademakers R; Filippi M; Jack CR; Lowe VJ; Parisi JE; Dickson DW; Josephs KA; Whitwell JL
    Ann Neurol; 2020 Nov; 88(5):1009-1022. PubMed ID: 32869362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET Imaging.
    Rauchmann BS; Ghaseminejad F; Mekala S; Perneczky R;
    Radiology; 2020 Jul; 296(1):134-142. PubMed ID: 32368960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.
    Liesinger AM; Graff-Radford NR; Duara R; Carter RE; Hanna Al-Shaikh FS; Koga S; Hinkle KM; DiLello SK; Johnson MF; Aziz A; Ertekin-Taner N; Ross OA; Dickson DW; Murray ME
    Acta Neuropathol; 2018 Dec; 136(6):873-885. PubMed ID: 30219939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Cody KA; Langhough RE; Zammit MD; Clark L; Chin N; Christian BT; Betthauser TJ; Johnson SC
    Brain; 2024 Jun; 147(6):2144-2157. PubMed ID: 38667631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.
    Young CB; Winer JR; Younes K; Cody KA; Betthauser TJ; Johnson SC; Schultz A; Sperling RA; Greicius MD; Cobos I; Poston KL; Mormino EC;
    JAMA Neurol; 2022 Jun; 79(6):592-603. PubMed ID: 35435938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review.
    Ferreira D; Mohanty R; Murray ME; Nordberg A; Kantarci K; Westman E
    Acta Neuropathol Commun; 2022 Nov; 10(1):166. PubMed ID: 36376963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.